Drug Profile
Levocarnitine injection - Lees Pharmaceutical Holdings
Alternative Names: CarniteneLatest Information Update: 18 Jun 2015
Price :
$50
*
At a glance
- Originator sigma-tau SpA
- Developer Lee's Pharmaceutical
- Class Amino acids
- Mechanism of Action Carnitine acetyltransferase stimulants; Free radical scavengers; Pyruvate dehydrogenase kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Chronic heart failure
Most Recent Events
- 31 Jan 2011 Phase-II/III clinical trials in Chronic heart failure in China (Injection)